|
1
|
TRV GP III
Boston,
Massachusetts
|
$122M
|
–
|
–
|
–
|
|
|
2
|
BB Biotech
Schaffhausen,
Switzerland
|
$54.9M
|
–
|
–
|
–
|
|
|
3
|
PFM Health Sciences
San Francisco,
California
|
$37.3M
|
+$25.4M
|
+1,951,061
|
New
|
|
|
4
|
|
$36.3M
|
+$455K
|
+34,954
|
+2%
|
|
|
5
|
Armistice Capital
New York
|
$29.4M
|
-$16.9M
|
-1,300,000
|
-46%
|
|
|
6
|
Vanguard Group
Malvern,
Pennsylvania
|
$26.6M
|
+$104K
|
+8,015
|
+0.6%
|
|
|
7
|
|
$21.6M
|
–
|
–
|
–
|
|
|
8
|
Farallon Capital Management
San Francisco,
California
|
$19.1M
|
+$1.19M
|
+91,000
|
+10%
|
|
|
9
|
Fidelity Investments
Boston,
Massachusetts
|
$14.1M
|
-$2.26M
|
-173,500
|
-19%
|
|
|
10
|
Highline Capital Management
New York
|
$11.3M
|
-$9.06M
|
-695,900
|
-54%
|
|
|
11
|
Renaissance Technologies
New York
|
$9.42M
|
+$782K
|
+60,000
|
+14%
|
|
|
12
|
Wellington Management Group
Boston,
Massachusetts
|
$9.42M
|
–
|
–
|
–
|
|
|
13
|
ClearBridge Investments
New York
|
$7.27M
|
+$4.94M
|
+379,565
|
+93,031%
|
|
|
14
|
State Street
Boston,
Massachusetts
|
$7.24M
|
+$163K
|
+12,540
|
+3%
|
|
|
15
|
Adage Capital Partners
Boston,
Massachusetts
|
$7.18M
|
–
|
–
|
–
|
|
|
16
|
Wells Fargo
San Francisco,
California
|
$6.93M
|
-$507K
|
-38,926
|
-10%
|
|
|
17
|
Geode Capital Management
Boston,
Massachusetts
|
$6.06M
|
+$385K
|
+29,539
|
+10%
|
|
|
18
|
BVF Inc
San Francisco,
California
|
$5.94M
|
+$4.04M
|
+310,299
|
New
|
|
|
19
|
|
$5.73M
|
-$176K
|
-13,505
|
-4%
|
|
|
20
|
Erste Asset Management
Vienna,
Austria
|
$5.71M
|
+$3.13M
|
+240,000
|
+407%
|
|
|
21
|
|
$5.61M
|
+$772K
|
+59,274
|
+25%
|
|
|
22
|
Northern Trust
Chicago,
Illinois
|
$5.37M
|
+$74.4K
|
+5,712
|
+2%
|
|
|
23
|
|
$4.88M
|
-$428K
|
-32,839
|
-11%
|
|
|
24
|
|
$4.61M
|
+$2.62M
|
+201,274
|
+512%
|
|
|
25
|
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
$3.88M
|
+$254K
|
+19,481
|
+11%
|
|
